Regeneron Pharmaceuticals’ $7 Billion Secondary Offering and $5 Billion Share Repurchase

Wachtell, Lipton, Rosen & Katz acted as special counsel to Regeneron Pharmaceuticals, Inc., while Ropes & Gray represented the lead underwriters in the offering. Regeneron Pharmaceuticals…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here